Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-09-006232
Filing Date
2009-03-27
Accepted
2009-03-27 09:23:33
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f51890e10vk.htm 10-K 1129392
2 EX-21.1 f51890exv21w1.htm EX-21.1 1912
3 EX-23.1 f51890exv23w1.htm EX-23.1 1432
4 EX-31.1 f51890exv31w1.htm EX-31.1 6296
5 EX-31.2 f51890exv31w2.htm EX-31.2 6283
6 EX-32.1 f51890exv32w1.htm EX-32.1 3507
7 EX-32.2 f51890exv32w2.htm EX-32.2 3511
  Complete submission text file 0000950134-09-006232.txt   1154080
Mailing Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 415-283-2200
VIA Pharmaceuticals, Inc. (Filer) CIK: 0001003929 (see all company filings)

EIN.: 330687976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27264 | Film No.: 09708190
SIC: 2836 Biological Products, (No Diagnostic Substances)